Hagens Berman Encourages Acadia Healthcare (ACHC) Investors with Losses to Contact the Firm, Investor Lawsuit Filed Over Allegations of Patient Mistreatment

Core Viewpoint - Acadia Healthcare Company is facing a class-action lawsuit from investors alleging misleading business practices, violating the Securities Exchange Act of 1934 [1][2]. Group 1: Allegations and Lawsuit Details - The lawsuit, filed in the Middle District of Tennessee, claims that Acadia made false or misleading statements about its operations from February 28, 2020, to October 18, 2024 [2]. - Specific allegations include that Acadia's business model involved holding patients against their will without medical necessity, subjecting patients to abuse, and deceiving insurance providers by billing for unnecessary patient stays [2]. - The lawsuit references a New York Times article published on September 1, 2024, which exposed Acadia's practices and led to a stock price drop of over 4% [3]. Group 2: Regulatory Scrutiny and Stock Impact - On September 27, 2024, Acadia disclosed receiving a subpoena from the U.S. District Court for the Western District of Missouri and a request for information from the U.S. Attorney's Office for the Southern District of New York, related to admissions practices and billing [4]. - This disclosure reportedly caused Acadia's stock price to plummet by more than 16% [4]. Group 3: Investigation and Whistleblower Information - Hagens Berman, a shareholder rights firm, is investigating the claims against Acadia, emphasizing the potential harm to both patients and investors [5]. - The firm encourages individuals with non-public information regarding Acadia to consider whistleblower options, which may offer rewards up to 30% of any successful recovery made by the SEC [5].